Steroid Hormones


Steroid hormones play a major role in bodily functioning because they are required for many critical physiological processes, including survival of stress, injury (and illness), metabolism, inflammation, salt and water balance, immune functions, and development of sexual characteristics. Notably, the steroid hormone, cortisol , is required for adaptation (in particular, to stress and to changing environments) and human life is not possible in its absence. In the previous chapter, it was pointed out that the release of these hormones from the cells in the end organ, synthesizing the particular steroid hormone, is under the control of the anterior pituitary hormones (except in the case of activated vitamin D, functioning as a steroid hormone, which will be discussed in this chapter). The pituitary hormones are released from specific anterior pituitary cells by releasing hormones from the hypothalamus. The releasing hormones are signaled by other neurons in the hypothalamus .

Stress

In most situations, stress is harmful. Although there is so-called healthy stress, the emphasis here is on stress events that can lead to damage. There are acute and chronic stresses. Acute stress is short-lived and usually invokes a “flight-or-fight” response. For example, walk through the woods and suddenly see a rattlesnake in your path. Catecholamines would pour out and you would turn and run as fast as possible. After the stressor has disappeared, the internal systems would normalize again; epinephrine, norepinephrine , and cortisol would have entered the bloodstream during the stress and, ultimately, these secretions would normalize again after the stress event is over.

Chronic stress , on the other hand, lasts over a long period with suppression of the “flight-or-fight” response. Long recoveries from surgery, long-term relationship problems, financial worries, and pressured work environment are examples. Long-term stresses can lead to elevated blood pressure, heart disease, suppression of the immune system, and even to diabetes (stress-induced diabetes) as well as other pathologies. Over long periods, stress causes an increase in the level of blood cortisol (also seen during aging ; so, aging itself may constitute a type of stress). Cortisol feeds back negatively on the hippocampus and amygdala of the limbic system that can lead to depression. As this chronic stress continues, the increase in circulating cortisol can cause the hippocampus, via the glucocorticoid receptor (GR), to shrink (cortisol induction of programmed cell death). Since the hippocampus is the center of memory , this also can account for memory losses. Even in acute stress, there can be short-term memory losses that are reversed during recovery. Another factor in the development of depression relates to the fact that part of serotonin’s action is to create a feeling of well-being and cortisol acts to suppress serotonin release . This form of depression is typical in aging.

Nociceptin

Nociceptin (also orphanin FQ ) is a 17-amino acid peptide (FGGFTGARKSARKLAMQ) anxiolytic that experimentally modulates anxiety produced by acute stress. While it is classified as an opioid , it binds to its receptor that is separate from the classical plasma membrane opioid receptors (kappa, mu, and delta); it binds to the nociceptin receptor called NOP1 . The kappa receptor (κ), KOR (another name for the kappa receptor), binds dynorphins (there is “big dynorphin,” dynorphin A and dynorphin B; big dynorphin and dynorphin A are more potent and selective than dynorphin B); the mu receptor (μ), MOR (another name for the mu receptor), binds β-endorphin and endomorphins (endomorphin 1 is YPYF); and the delta receptor (δ), DOR, binds enkephalins (Met-enkephalin is YGGFM and Leu-enkephalin is YGGFL). Remember that in the anterior pituitary, preproopiomelanocortin is the precursor of β- endorphin and Met-enkephalin ( Fig. 15.6 ). The precursor of nociceptin in nociceptinergic neurons is prepronociceptin . It is a polypeptide of 176 amino acids that is degraded by enzymes that cleave at basic amino acid sites into a signal peptide and active peptides: amino acids 1–19 constitute a signal peptide, amino acids 20–95 constitute a spacer peptide, amino acids 98–127 constitute neuropeptide 1 ( nocistatin ), amino acids 130–146 constitute nociceptin, amino acids 149–165 constitute neuropeptide 2 ( Nocil ), and amino acids 169–176 constitute the C-terminal peptide fragment. The NOP is distributed throughout the brain, including the limbic system (e.g., hippocampus and amygdala), and spinal cord and the nociceptin-NOP system are present both in the central nervous system and in the peripheral nervous system where it modulates nociception , the transmission of pain . Nociceptin binds to NOP in neurons where it reduces the activation of adenylate cyclase , reduces the activity of calcium channels , and also opens potassium channels (similarly to the action of opioids).

Responses to Stress

The release of catecholamines in short-term stress and the release of glucocorticoid in long-term stress are shown in Fig. 16.1 .

Figure 16.1, Responses to stress. Sympathetic nervous system responses are shown on the left and hormonal responses are shown on the right .

A stress event , evoked from the external or internal environment, is filtered in the brain by some mechanism, probably sensory gating (involving the thalamus) so that certain stimuli are rejected from further reaction. However, many forms of stress, especially psychological stressors (job insecurity, abuse, marital problems, etc.) or acute stressors (loud noises, sudden fright, etc.), set into motion the short- and long-term effects of stress shown in Fig. 16.1 . Some sort of signal (possibly an electrochemical signal), following a stress event, impacts the hypothalamus and it sends impulses through the spinal cord to preganglionic fibers that innervate the adrenal medulla resulting in the secretion of epinephrine and norepinephrine into the bloodstream. The elevation of these catecholamines in the circulation causes rapid increases in heart rate, blood pressure, and metabolic rate and stimulates the dilation of the bronchioles as well as causing the conversion of glycogen to free glucose for energy use.

The hypothalamus releases corticotropin-releasing hormone ( CRH ) into the portal blood system, enclosed by the stalk, and generates the release of adrenocorticotropin hormone ( ACTH ) from the corticotropic cells of the anterior pituitary. ACTH circulates to the adrenal cortex where it binds and activates its receptor on the plasma membranes of adrenal cortex cells resulting in the synthesis and release of the glucocorticoid cortisol and the mineralocorticoid aldosterone . Aldosterone is also released by acetylcholine during stress and by angiotensin II (Ang II) .

Cortisol circulates in the bloodstream and crosses the plasma membranes (presumably by free diffusion owing to its lipid solubility) and freely passes back out to the extracellular space if there is little receptor available in the cytoplasm of the cell. Target cells, like the hepatocyte, have large amounts of the cytoplasmic receptor and cortisol is sequestered thereby binding to the receptor molecules. Kidney cells also have large amounts of the receptor. Virtually, all the cells in the body have some receptor molecules, except hepatobiliary cells and cells in the space between the anterior and posterior pituitary, so it can be said that some cortisol is taken up by all cells except the two forms indicated. As a result, there is protein and lipid breakdown, the products of which are converted to blood glucose. Also glucose uptake by peripheral tissues is inhibited resulting, in the short term, of about a 10% increase in the blood level of glucose, enough to cause a release of insulin from the pancreatic β-cell. In itself, it is not a harmful response but if continued over a long period, the pressure to release insulin from unrelenting stress events could lead to stress-induced diabetes through exhaustion of the β-cells’ ability to produce and secrete insulin. Also, in prolonged stress, suppression of the immune system and breakdown of muscle protein together with decreased protein synthesis can occur.

Aldosterone , a true stress hormone, causes the retention of sodium by its actions on the kidney and increases blood volume (by increasing water reabsorption) and blood pressure. Whereas cortisol secretion (primarily from zona fasciculata cells of the adrenal cortex) occurs endogenously under the control of serotonin , in stress, its secretion is added to the endogenous level. This accounts for the nearly 1000 times higher circulating level of cortisol (up to 25 μg/dL) compared to aldosterone (up to about 30 ng/dL). Aldosterone is secreted primarily as the result of stress. Abnormally, high-salt ingestion will increase the blood level of aldosterone. In addition to the action of ACTH on the zona glomerulosa cell (outer cells of the adrenal cortex), aldosterone is also released by the action of Ang II and hypokalemia as shown in Fig. 16.2 .

Figure 16.2, Activities of stress, hypokalemia, and angiotensin II on the synthesis and release of aldosterone from the cells of the outer layer of the adrenal cortex, the zona glomerulosa . The actions of ACTH and ANF also are shown. Many effects result in the mobilization of calcium ions that stimulate the release of aldosterone. ANF , Atrionatriuretic factor; AT , angiotensin; c , cyclic; DAG , diacylglycerol; G , G protein; GMP , guanosine monophosphate; GTP , guanosine triphosphate; IP 3 , inositol tris phosphate; PKA , protein kinase A; PKC , protein kinase C.

Besides causing the release of aldosterone from the zona glomerulosa , Ang II has many other activities. It constricts blood vessels, especially the efferent arterioles of the kidney causing increased sodium ion and water retention. Sodium retention also is promoted by the direct action of Ang II on proximal tubules. It increases thirst by acting on the hypothalamus and stimulates the secretion of antidiuretic hormone , ADH (AVP) from the posterior pituitary, thus increasing water reabsorption , among other actions. Ang II stimulates tyrosine kinases (pp60 c-src ) focal adhesion kinases and JAK2 , TYK2 kinases that are involved in vasoconstriction of vascular smooth muscle, protooncogene expression, and protein synthesis. The angiotensin precursor is formed in the liver and converted to Ang II in the lungs.

Aldosterone is secreted from the zona glomerulosa cell into the bloodstream and circulates to the tissues. The cellular targets, especially the distal kidney tubular cell , contain cytoplasmic mineralocorticoid receptors (Mrs) to which aldosterone binds (there is a very small percentage of mineralocorticoid-like receptors in the plasma membrane that, when activated, probably play a small role in ion transport; plasma membrane “Mrs” may be proteins different from the classical receptor). The binding of the steroid hormone activates the receptor complex, causing the release of bound heat shock proteins and the dimerization of the monomeric receptor protein. The dimer translocates to the cellular nucleus and binds to the appropriate steroid response element in various promoter elements to activate genes encoding the serum- and glucocorticoid-induced kinase ( Sgk ), the Kirsten-ras A oncogene protein , and CHIF , the corticosteroid hormone–induced factor that stimulates the formation of potassium uptake channels. The actions of aldosterone on the principal cells of the kidney are shown in Fig. 16.3 .

Figure 16.3, Mineralocorticoid receptor-mediated effects of aldosterone in the principal cells of the kidney. The kidney collecting duct cells are of two types: the principal cell and the intercalated cell. The result is the increase of sodium reabsorption and potassium excretion. 11β-HSD 2 , 11β-Hydroxysteroid dehydrogenase 2; ALDO , aldosterone; CHIF , corticosteroid hormone–induced factor; it is a small epithelial-specific transmembrane protein interacting with a subunit of Na + –K + -ATPase that increases the pump’s affinity for cellular Na + and participates in the regulation of ion transport ; ENaC , epithelial sodium channel; Hsp , heat shock protein; Mr , mineralocorticoid receptor; SRE , steroid response element.

The activation of the ACTH receptor by binding ACTH occurring on the zona fasciculata cell (the intermediate layer of cells in the adrenal cortex) membrane of the adrenal cortex to generate the synthesis of cortisol and its secretion is shown in Fig. 16.4 .

Figure 16.4, Regulation of steroidogenesis by plasma membrane hormone receptors in zona fasciculata cells of the adrenal cortex. ACTH is the physiological modulator of cortisol production in the adrenal cortex. Binding to its receptor (ACTHR; also known as the MC2R) activates AC leading to the production of cAMP from ATP and the activation of PKA that phosphorylates specific protein TF listed on the left of the figure. mRNAs produced are translated into the proteins involved in the synthesis of cortisol. PKA phosphorylates and activates cholesteryl ester hydrolase that converts cholesteryl ester in the droplet to free cholesterol that can enter the mitochondrion. The other ectopic receptors for GIP and the catecholamines, E, and NE on the cell membrane may contribute to the synthesis of cortisol by generating cAMP to increase the activation of PKA . AC , Adenylate cyclase; ACTH , adrenocorticotropin hormone; ACTHR , adrenocorticotropin hormone receptor; ATP , adenosine triphosphate; cAMP , cyclic adenosine monophosphate; E , epinephrine; GIP , gastric inhibitory peptide; M , mitochondrion; MC2R , melanocortin 2 receptor; N , nucleus; NE , norepinephrine; PKA , protein kinase A; TF , transcription factors.

Cortisol is synthesized and released from the fasciculata cell, enters the bloodstream, and is carried through the adrenal medulla to the general circulation. In the medulla the hormone induces the formation of catecholamines by inducing a key enzyme, phenylethanolamine N -methyltransferase . Cortisol circulates to the tissues entering most of the cells; in the target cells, there are many molecules of the cytoplasmic GR that bind cortisol. The retention of cortisol within a cell depends on the concentration of its receptor, the liver and kidney cells having the largest amounts. The receptor complex becomes activated, enters the nucleus as a dimer (some models show the receptor as forming a dimer in the nucleoplasm), and binds to the glucocorticoid response elements (GREs) of various genes to produce many different mRNAs and subsequently their protein counterparts. These events are pictured in Figs. 16.5 and 16.6 .

Figure 16.5, The GR mechanism is shown in the upper right . Unbound cortisol in the blood enters the target cell by free diffusion and binds to the inactive receptor complex (one molecule of receptor is bound to a dimer of HSP90 and other proteins). Upon binding the steroid a conformational alteration in the receptor occurs along with the dissociation of HSP90 and other proteins. The receptor becomes phosphorylated by MAPK , or by CDK , or by both on threonine and serine residues. MAPK and CDK phosphorylate different amino acid residues. The receptor, thus activated, is (dimerized and then) translocated to the cellular nucleus where it can affect the steroid response elements in various ways as shown in the left bottom of the figure. On the left side of the figure is shown the JAK-STAT pathway that, in some cases, interacts with GR on DNA. Cytokines , such as IL-2 and IL-6, induce JAK and activate STAT proteins. JAK phosphorylates monomeric STAT proteins in the cytoplasm, and the phosphorylated STAT proteins dimerize and translocate to the nucleus where they bind to response elements and regulate gene expression for growth, survival, apoptosis, host defense, stress, and differentiation. In some cases the GR interacts with members of the STAT family to enhance STAT-mediated gene expression. STAT proteins can either enhance or repress GR-mediated gene activation depending on the stimulus and the specific STAT protein involved. At the bottom of the figure, STAT refers to the STAT response element and GRE refers to the glucocorticoid response element . CDK , Cyclin-dependent kinase; GR , glucocorticoid receptor; HSP90 , heat shock protein 90; JAK-STAT , Janus family tyrosine kinase-signal transducer and activator of transcription; MAPK , mitogen-activated kinase.

Figure 16.6, Basic mechanisms of GR action. Left : the GR resides in the cytoplasm complexed with several chaperones , including Hsp90 and immunophilin p59 . When cortisol binds to the receptor complex, the accessory proteins dissociate, and the receptor dimerizes and translocates as a dimer to the nucleus (although dimerization is not shown to occur in the cytoplasm in this figure). Middle : the GR regulates the expressions of genes by several basic modes of action. From top to bottom : the dimeric GR binds to glucocorticoid response elements in target genes to activate gene transcription; the GR binds to nGREs and inhibits target gene transcription; the GR physically interacts with the c-Jun subunit of the AP-1 complex to inhibit AP-1-mediated gene transcription; the GR physically interacts with the p65 (RelA) subunit of NF - κB and represses NF - κB-regulated gene expression; the GR physically interacts with members of the STAT family (STAT1, STAT3, and STAT5) and synergistically enhances STAT-regulated gene transcription . Right : examples of genes regulated by the GR by the various mechanisms are shown. GR , Glucocorticoid receptor; GTM , general transcription machinery; Hsp90 , heat shock protein 90; NF - κB , nuclear factor kappaB; nGREs , negative glucocorticoid response elements; P , phosphate; STAT , signal transducer and activator of transcription.

It is uncertain as to in what compartment, the receptor complex dimerizes since some mechanistic schemes show the receptor entering the nucleus as a dimer, whereas in the illustrations here, the GR enters the nucleus as a monomer. In Fig. 16.6 , examples are shown of the response elements in gene promoters in which the GR dimer is involved: the GRE where the receptor dimer positively transcribes the message for genes like tyrosine aminotransferase ; the STAT (signal transducer and activator of transcription) response element positively regulating the protein, casein and the negative regulator, nGRE , that downregulates the osteocalcin gene; the AP-1 response element where Fos/Jun binds and then the GR binds to c-Jun to downregulate collagenase and the nuclear factor kappaB ( NF- κB) response element where the receptor binds to the subunits of NF - κB to downregulate interleukin (IL)-1β.

The endogenous secretion of cortisol under the control of a serotonergic neuron is highest at about 8:00 a.m. and falls to lower levels during the day; it will rise again to its peak at 8:00 a.m. on the next day. During individual stress events the released cortisol in the blood is added to the circulating cortisol derived from the serotonin-induced endogenous release. The incidence of heart attacks may be associated with the highest endogenous level of cortisol in the blood and many occur in the early morning.

Although these responses to stressors reoccur after each stress event, eventually, an adaptive process must take place allowing the survival of the individual. Such adaptation may occur in the brain in the form of epigenetic modifications in the brain cells’ DNA to allow the expression of genes that are required for the stressed individual to adapt.

Production of High Levels of Cortisol (Cushing’s Disease) and Subnormal Levels of Cortisol (Addison’s Disease)

Normally, in response to serotonin for the endogenous production of cortisol and in response to a stress event, CRH is released from the hypothalamus causing the output of ACTH from the corticotrope of the anterior pituitary. ACTH enters the bloodstream and binds to ACTH receptors on the cells of the zona fasciculata of the adrenal cortex resulting in the synthesis and release of cortisol into the bloodstream. In Cushing’s disease , there is an overproduction of cortisol. The cause is often a tumor in the anterior pituitary that is producing abnormally high amounts of ACTH. This results in overstimulation of the adrenal zona fasciculata cells that synthesize and secrete abnormally high levels of cortisol. The usual negative feedback occurs by cortisol on the CRH neurons and the corticotrope but the tumor itself may not respond to this negative feedback (it may express little or no GR ). A high level of cortisol in the blood is the result. Hypercortisolism , typical of Cushing’s disease, also can be caused by ectopic tumors that produce ACTH and, occasionally, a tumor can produce CRH resulting in the abnormally elevated production of ACTH. Overproduction of ACTH can lead to hyperpigmentation because α-melanocyte-stimulating hormone (α-MSH) is produced from ACTH by cells in the space between the anterior and posterior pituitary. Hypercortisolism generates symptoms of rapid weight gain, especially of the trunk and face and growth of fat pads along the collar bone, excessive sweating, dilation of capillaries often generating purple or red striae (stripes or lines) due to hemorrhage, elevation of blood glucose level that can lead to diabetes , hypertension , and others.

Underproduction of cortisol ( Addison’s disease ) is due to chronic adrenal insufficiency in which there is abnormally low production of adrenal steroids (cortisol and aldosterone ). In this somewhat rare disease, cells of the adrenal cortex may have been destroyed by autoimmunity or by infectious agents or the adrenal cortex can be poorly formed from underdevelopment. There are many symptoms: weight loss, anxiety, nausea, headache, diarrhea, mood swings, sweating, low blood pressure, and hyperpigmentation of the skin (this time caused by insufficient negative feedback by cortisol on the corticotrope so that ACTH is overproduced and its breakdown by cells in the pars intermedia area generates α-MSH). There are symptoms of muscle weakness, lightheadedness, fatigue, fever, muscle and joint pains, vermillion border of the lips, and a low concentration of blood sodium with elevated calcium ions and potassium ions. Addison’s disease is treated by oral administration of adrenal steroids so that a near-normal existence can be obtained.

Adrenal Cortex

The adrenal gland is located within masses of fat above the kidneys. The adrenal has two structures, the outer adrenal cortex and the inner adrenal medulla . The adrenal cortex consists of three layers of cells internal to the outer capsule. The layer directly beneath the capsule is the zona glomerulosa and this layer of cells secretes mainly aldosterone in response to stress signals. The thick middle layer of cells is the zona fasciculata and its main secretion product is cortisol in response to ACTH and indirectly to serotonin (through CRH and to ACTH) forming the endogenous production of cortisol. The innermost layer of the cortex is the zona reticularis and its main secretion products are weak androgens, in particular, dehydroepiandrosterone ( DHEA ) plus some androstenedione . Reactions leading to all of the individual steroid hormones are shown in Fig. 16.7 .

Figure 16.7, Pathways of the syntheses of steroid hormones showing intermediates, enzymes involved in each step and their locations: pink , mitochondria; green , smooth endoplasmic reticulum. Yellow background shows pathways for progestogens (21 carbons); light blue background shows pathways for androgens (19 carbons); purple oval background , mineralocorticoids (21 carbons); green oval background , glucocorticoids (21 carbons). All steroid hormones are formed from cholesterol and cholesterol forms Δ 5-pregnenolone which is the mandatory intermediate. Progestogens are formed in the corpus luteum (see discussion of the ovarian cycle) and in the accessory tissue of pregnancy; dehydroepiandrosterone is formed in the zona reticularis of the adrenal cortex and the stronger androgens, testosterone and dihydrotestosterone , are formed in the Leydig cells of the testes; estradiol and related products are formed in the ovary and in the mammary gland; aldosterone is formed mainly in the zona glomerulosa of the adrenal cortex and cortisol is formed in the zona fasciculata cells of the adrenal cortex. Cholesterol side-chain cleavage ( upper left ) occurs in the mitochondria.

The fetal adrenal gland consists mainly of zona reticularis type cells. The other layers of cells develop near birth.

Aldosterone levels, similar to cortisol, fluctuate during the day because ACTH also releases some aldosterone in addition to cortisol. The stimulation of aldosterone by ACTH is short term, whereas the stimulation of cortisol by ACTH is longer term. Consequently, the blood concentrations of aldosterone are very much smaller than those of cortisol. Also, cortisol levels respond both to the endogenous pathway elicited by serotonin and to stress events, whereas the secretion of aldosterone is mainly the result of stress events. In the absence of ACTH , sodium depletion activates the renin–angiotensin system that elevates the synthesis of aldosterone as shown in Fig. 16.8 .

Figure 16.8, The renin–angiotensin system is stimulated by a decrease in blood volume or a decrease in sodium ion concentration. This causes an increase in the synthesis and release of aldosterone from the zona glomerulosa of the adrenal cortex. ANH , Atrionatriuretic hormone.

Details of the action of the hormones Ang II and ACTH and acetylcholine in response to stress are shown in Fig. 16.2 . The hormone angiotensin is derived from the precursor, angiotensinogen (480 amino acid polypeptide), synthesized in the liver. Angiotensinogen is cleaved by the kidney proteolytic enzyme, renin , to produce angiotensin I (10 amino acids). Angiotensin I is further cleaved by the lung enzyme, angiotensin-converting enzyme ( ACE ) to yield an octapeptide-containing amino acid 1–8. This ( right side ) form can be further converted to angiotensin IV (amino acids 3–8) and angiotensin III (amino acids 2–8). Angiotensin I is converted to Ang II , the major form of the hormone , by ACE and Ang II binds to its receptor (AT1R) to produce hypertension , vasoconstriction , and cardiovascular disorders . Alternatively, angiotensin I can be cleaved by angiotensin-converting enzyme 2 (ACE2) to produce angiotensin 1–9 or it can be cleaved by neprilysin to produce angiotensin 1–7. If angiotensin 1–7 binds to the Mas receptor or if Ang II binds to the renal AT2 receptor (AT2R), opposite reactions are obtained (antihypertension, vasodilation, and cardiovascular protection). These reactions are depicted in Fig. 16.9 .

Figure 16.9, Processing of angiotensin peptides by ACE, ACE2, and NEP as part of the renin–angiotensin system. Kidney renin cleaves angiotensinogen from liver to produce angiotensin I (DRVYIHPFHL). ACE, in lungs, converts angiotensin I to angiotensin II (DRVYIHPF). In a second processing axis, angiotensin I is cleaved by ACE2 resulting in angiotensin 1–9 (DRVYIHPFH) that is cleaved by either ACE or NEP to produce angiotensin 1–7 (DRVYIHP). This product also can result from the action of NEP on angiotensin I or the action of ACE2 on angiotensin II . Binding of angiotensin II to its receptor AT1R activates vasoconstriction . In contrast, binding of angiotensin II to the AT2R mediates vasodilation that also can be initiated by the binding of angiotensin 1–7 to the Mas receptor . ACE , Angiotensin-converting enzyme; AT1R , AT1 receptor; AT2R , AT2 receptor; NEP , neprilysin.

There are abundant physiological effects of Ang II directly and through its stimulation of the secretion of aldosterone . Ang II causes increased blood pressure through its constriction of blood vessels. Ang II has important effects on the kidney microcirculation and acts directly on the proximal tubules to cause sodium retention . Through the release of aldosterone and its effects on the collecting tubules, there are increases in plasma sodium ion concentration and reductions in potassium ions and hydrogen ions. Aldosterone acts on the hypothalamus to cause thirst and the secretion of ADH (AVP). Ang II potently constricts both afferent and efferent arterioles in the kidney microvasculature [its responses can be regulated by both paracrine (from neighboring cells) and autocrine (from its own cell) factors derived from the endothelium and from the macula densa ]. The concentration of Ang II determines the extent of tubuloglomerular feedback activity, especially when the concentration of the protease renin (from the macula densa ) is elevated. The vascular effects of Ang II are primarily mediated by the AT1R. In the fetus, AT2R is expressed in the kidney and is critical for kidney development but seems to be expressed less strongly in the adult. As shown in Fig. 16.9 , the AT2R–Ang II complex can mediate vasodilation.

Regarding the effects of Ang II on the afferent arteriole (blood vessel carrying blood to the glomerulus), it constricts this vessel by stimulating the entry of calcium ions through voltage-sensitive L-type channels , while the constriction of efferent arterioles (blood vessel carrying blood away from the glomerulus) results from the release of calcium ions from intracellular stores and the uptake of calcium ions through voltage-independent channels to cause back pressure at the glomerular capillaries.

Significantly, angiotensin receptors are expressed in the brain, kidney, adrenal, vascular wall, and in the heart. ACE2, related to ACE, is expressed in the endothelium of the coronary, intrarenal vessels, and in the epithelium of the renal tubules. Ang II can stimulate tyrosine kinases [pp60 c-src , focal adhesion, and Janus kinases (JAK2, TYK2)]. These tyrosine kinases may be involved in the vasoconstriction of vascular smooth muscle, protein synthesis, and protooncogene expression.

Aldosterone , released from the zona glomerulosa cell, circulates in the bloodstream and binds to its receptors in the cytoplasm of its cellular targets, principally the distal kidney tubular cell , and exerts the effects shown in Fig. 16.3 . The action of aldosterone causes sodium ion reabsorption from the tubular urine while potassium ion is secreted. Aldosterone signal transduction increases epithelial sodium ion channels (ENaC) in the apical membrane while increasing Na + /K + -ATPase in the basolateral membrane and these represent slow responses (taking place about 6–24 hours after aldosterone). The rapid and genomic responses to aldosterone ( Fig. 16.3 ) are the elevation of Sgk , the CHIF , and Kirsten ras and these actions occur in the first 6 hours after aldosterone. Very rapid ion transport responses to aldosterone that occur before gene regulation are possible and could be due to a direct effect on a small fraction of “aldosterone receptors” located in the cell membrane. Fig. 16.10 explains recent information on the genomic and nongenomic effects of aldosterone indicating that the membrane aldosterone receptor may be due to the action of a protein (possibly G protein–coupled receptor 30) that is different from the classical aldosterone Mr that operates genomically.

Figure 16.10, An hypothetical model describing membrane-initiated rapid aldosterone signaling. The classical Mr is translocated to and is associated with the membrane in a signaling complex, including striatin (calmodulin-binding protein), Cav 1 , src, and the EGF-R . Similar associations have been described for the estrogen receptor, androgen receptor, and progesterone receptor. Upon aldosterone stimulation, Mr is released from the membrane-signaling complex and EGF-R is translocated by aldosterone initiating c-src-mediated MAPK activation. In addition, GPR 30 may function as an aldosterone receptor mediating rapid Mr-independent signaling. ALDO , Aldosterone; Cav 1 , caveolin 1; EGF-R , epidermal growth factor receptor; GPR , G protein–coupled receptor; MAPK , mitogen-activated protein kinase; Mr , mineralocorticoid receptor.

Rapid responses after 6 hours elevate the number of transport proteins allowing the reabsorption of sodium ion from the tubular urine. The uptake of sodium ions is followed by the passive reabsorption of water to maintain a constant concentration of sodium causing the extracellular volume to expand and increasing blood pressure.

If the plasma volume is decreased ( hypovolemia ), the protease, renin , is secreted from the granular cells of the juxtaglomerular apparatus . Renin degrades liver-expressed angiotensinogen to yield angiotensin I and pulmonary ACE cleaves a dipeptide from the C-terminus of decameric angiotensin I to produce octomeric Ang II ( Fig. 16.9 ). The action of Ang II on the zona glomerulosa cell of the adrenal cortex generates the synthesis and release of aldosterone , the effects of which also increase blood volume and pressure. One of the effects of aldosterone is to cause K + to move into the extracellular space ( Fig. 16.3 ) and ultimately into the urine. Potassium ion depolarizes the zona glomerulosa cell and because its entry into the cell stimulates the synthesis of aldosterone, the removal of K + into the urine acts as a negative feedback [there is also a negative effect of the atrionatriuretic hormone (ANH or ANF) on the synthesis of aldosterone].

Structures of Steroid Hormone Receptors

The structures of the glucocorticoid (cortisol) receptor and the mineralocorticoid (aldosterone) receptor are similar; their N-terminal domains, however, are quite different. Fig. 16.11 shows a cartoon depicting the domains of several of the hormone receptors in the steroid hormone receptor gene family .

Figure 16.11, (A) The hormone receptor is pictured as a horizontal bar divided into the functional domains A through F. Regions of the various activities of the receptors are shown below. (B) The genomic organization of some of the receptors in the steroid receptor hormone gene family is shown. There are other receptors that are members of this gene family and some will be addressed in separate discussions. Genes for these receptors encompass about 60 kb and are interrupted by numerous introns. Promoters of these genes resemble housekeeping genes and may be embedded in GC-rich islands . There are multiple sites of transcriptional initiation. Numbers to the left of each entry indicate the numbers of amino acid residues in the protein. The numbers in yellow indicate the percentage homology in the DNA-binding domain referring to the GR arbitrarily taken as the standard. The numbers on the right over the long blu e region of E also indicate the extent of homologies of the LBD s referring to the GR arbitrarily taken as standard. Note that the DNA-binding regions ( DBD s) of the GR (100) and Mr (94) are similar and, in many cases, both receptors bind to the same promoters in target genes. The ligand-binding domains somewhat overlap for GR, Mr, PRβ, and AR and all four bind the same ligands to different degrees, although a ligand activating one receptor (e.g., PRβ) may be an antagonist for another (e.g., GR). AD , Antigenic domain; AR , androgen receptor ; DBDs , DNA-binding domains; ER , estrogen receptor ; GR , glucocorticoid receptor; LBDs , ligand-binding domains; Mr , mineralocorticoid receptor; PRβ , the beta form of the progesterone receptor ; RARβ , the beta form of the retinoic acid receptor ; TRβ , the beta form of the thyroid hormone receptor ; VDR , vitamin D receptor ; τ , tau (transactivation function).

There are many other receptors assigned to the steroid hormone receptor gene superfamily . In addition to those listed in Fig. 16.11 , the following are also members: thyroid hormone receptors (in addition to TRβ): TRα1 and TRα2; c-erbA1 and Rev-Erb; RARα and RARγ in addition to RARβ listed in the figure; RXRα, RXRβ, and RXRγ (retinoic acid receptors activated by 9- cis -retinoic acid), whereas RARs are activated by all trans-retinoic acid and 9-cis-retinoic acid ; and PPARα, PPARβ, and PPARγ (peroxisome proliferator-activated receptor) that bind fatty acids , including ω6 atherogenic lipids, and fatty acid derivatives; there are numerous synthetic compounds (e.g., thiazolidinediones) that bind with high affinity but all of the physiological ligands are not known.

There are a whole series of receptors that fall into this class that are labeled as orphan receptors ; some of these now have ligands that have been identified (the benzoate X receptor; the pregnane receptor; the liver X receptor; CARβ, a constitutive androstane receptor; FXR, a farnesoid receptor and hSXR, a steroid and xenobiotic receptor). Additionally, there are a number of orphan receptors, the human physiological ligands of which are unknown (original definition of an “orphan” receptor). Among these are the chicken ovalbumin upstream promoter (COUP) receptors (COUP-TFOI/EAR and COUP-TFII/ARP-1), DAX-1, SHP (Src homology 2 domain), nur77/NGF1-B, ERR1 and ERR2, HNF-3 and HNF-4, and SF-1.

The ligand-binding domain ( LBD ) of the GR is shown in Fig. 16.12 . This receptor will be used as a model, although the LBDs of other receptors in this family also have been reported.

Figure 16.12, The LBD of the glucocorticoid receptor. The ligand, dexamethasone, a synthetic steroid for which the receptor has much higher affinity (~50-fold) than for cortisol, is shown within the LBD in gray . A similar structure is superimposed upon dexamethasone (in purple ). The inset shows dexamethasone (structure) bound in the LBD relative to the entire glucocorticoid receptor. LBD , Ligand-binding domain.

The binding of the ligand induces conformational changes in the receptor causing the associated nonreceptor proteins to dissociate ( Fig. 16.5 ). The relative affinities of the receptor for various steroid ligands are presented in Table 16.1 . Remembering that the LBDs of some of the receptors in this class are homologous to a certain extent, some of the ligands listed are bound, not only to the GR, but also to the Mr and to other receptors.

Table 16.1
Compounds Related to Cortisol Which Have Glucocorticoid Activity (Antiinflammatory) and/or Mineralocorticoid Activity (Salt-Retaining).
Mineralocorticoid Antiinflammatory
1 1
800 1
800 5–40
40 0
0.6 4
0 5
0 5–100
0 10–35
0 >100

Structures of the ligands for many of the receptors in this class are shown in Fig. 16.13 .

Figure 16.13, The chemical structures of ligands for some of the receptors in the steroid hormone nuclear receptor family. AR , Androgen receptor; ER , estrogen receptor; GR , glucocorticoid receptor; Mr , mineralocorticoid receptor; PPAR , peroxisome proliferator-activated receptor; PR , progesterone receptor; RAR , retinoic acid receptor binding all trans -retinoic acid; RXR , retinoic acid receptor also binding 9- cis -retinoic acid; TR , thyroid hormone receptor; VDR , vitamin D receptor.

As Table 16.1 shows, there are crossovers in ligand binding between the GR (antiinflammatory) and the Mr (salt-retaining). Both receptors bind cortisol equally well . They both bind prednisolone to differing degrees. While there is crossover in certain binding of ligands, the overall physiological actions of these receptors appear distinct, although, in some cases, the activated receptors may bind to the same gene promoters. Presumably, in addition to common promoters, there exist specific promoters for Mr and for GR. When there is a gene knockout of either of these receptors, different physiological consequences are encountered but death occurred in both cases. When the GR is knocked out in mice, most of the experimental animals die shortly after birth, primarily due to pathologies in the lungs but also from pathologies in the liver, adrenal glands, brain, thymus, and bone marrow (all of these tissues normally express the GR), and there is interference in the feedback regulation of the hypothalamic–pituitary axis because the negative feedback of cortisol requires the activation of GRs in the responding tissues. In the case where a similar knockout of the Mr , by targeted gene disruption, was performed, the newborns die of dehydration as a major effect of renal sodium and water loss with increased potassium ion in plasma, decreased sodium ion concentration, and elevated levels of components of the angiotensin system, namely, renin , Ang II and aldosterone , and elevated expression of renin, angiotensinogen , and Ang II receptor (ACE, angiotensin I-converting enzyme, in the kidney was not affected). It should be remembered that although there exist similarities in the LBDs and in the DNA-binding domains (DBDs), the N-termini of these receptors are widely different and must contribute to the differing actions of the two receptors, perhaps by attracting different activation factors to the Tau1 domain in the N-terminus. The hyperphosphorylation s of GR occur in the N-terminus and regulate the negative charge in this region.

The DBDs of receptors in the steroid receptor gene family have some homology as shown in Fig. 16.10 . In the case of the GR [and the Mr and androgen receptor (AR)], the DBD consists of two zinc fingers. The left zinc finger is closer to the N-terminus and the right zinc finger is downstream from the left zinc finger ( Fig. 16.14 ).

Figure 16.14, Organization and structure of the DNA-binding domain of the Mr, GR, and AR genes. Above, beige boxes , untranslated exons, blue boxes , translated exons. Below: amino acid sequence of the partial Mr is shown in one-letter code. Amino acids with a plus sign form α-helices. AR , Androgen receptor; DBD , DNA-binding domain; D-box , distal box; black letters , DNA identification sequence; GR , glucocorticoid receptor; HRE , hormone-responsive element; Mr , mineralocorticoid receptor; P-box , proximal box; ZF , zinc finger.

The zinc fingers of the homodimer of GR and other receptors associate with DNA in the major groove as shown in Fig. 16.15 .

Figure 16.15, Sequence-specific recognition of DNA by nuclear receptors. The core half-site recognized by a nuclear receptor is based on amino acid residues within the P-box . The sequence shown in this figure is for the ER . The helical structure of the P-box provides contacts with the major groove of the DNA helix. The shaded residues in the D-box are important for interactions with the phosphate groups of the DNA helix as well as for dimerization. ER , Estrogen receptor.

Steroid receptors bind to response elements in the promoters of the genes they affect. In the case of the GR, the response element is a sequence of two half-sites: 5′ AGAACAnnnTGTTCT 3′ (or on the complementary strand: 3′ TCTTGTnnnACAAGA 5′) where n is any nucleotide. This is the general response element for Mr, AR, and progesterone receptor (PR) as well as for GR. There are differences in the DNA base contact points when the receptors other than the GR bind to this palindromic sequence (same sequence whether read 5′–3′ on one strand or 5′–3′ on the complementary strand). The GRE is located on a large number of different gene promoters. In many cases the response element is positive and promotes the synthesis of an mRNA that leads to the synthesis of a new protein or, conversely, the response element could be negative and generate repression of specific gene activation. Examples of positive GREs are those located in genes for tyrosine aminotransferase and enzymes of gluconeogenesis. Examples of negative GREs are those that reside in genes for gonadotropin-releasing hormone (GnRH), prolactin, or proopiomelanocortin.

The major receptors of the steroid hormone receptor gene family and their hormone response elements are shown in Fig. 16.16 .

Figure 16.16, Hormone response element-binding sites for steroid/nuclear receptors. The half-sites of the response elements are shown for the various receptors. Note the orientations of the half-sites that are indicated by the directions of the arrows. ERE , Estrogen response element; G/ERE , glucocorticoid or estrogen response element; GRE , glucocorticoid response element; RARE , retinoic acid response element; TRE , thyroid hormone response element; VD 3 RE , vitamin D response element.

There are four classes of nuclear receptors . Class I (also referred to as type 1) receptors are those located in the cytosol and when the ligand binds to the unliganded receptor complex, ancillary proteins (e.g., heat shock proteins, HSP90) dissociate, homodimerization takes place followed by nuclear translocation and binding to hormone-responsive elements (see Fig. 16.16 ). GR, AR, estrogen receptor (ER), and PR are representatives of class I. Class II receptors are retained in the nucleus with or without ligand and bind to DNA as heterodimers, often with RXR, and are in complex with corepressor proteins in the absence of the ligand. When the ligand binds, the corepressor proteins dissociate and coactivator proteins are recruited. Then, an array of other proteins forms a complex along with RNA polymerase and transcription of DNA follows to form an mRNA. Class III receptors resemble class I because they bind DNA as homodimers that bind to direct repeats instead of inverted repeats. Class IV receptors bind to DNA in the form of dimers or monomers; however, there is only one DBD that binds to a single half-site hormone response element. These distinctions are further clarified in Fig. 16.17 .

Figure 16.17, The nuclear receptor superfamily. Top : Cartoon of the activity domains of the typical steroid receptor. Below are the classes of receptors in this superfamily. Class I, upper left ; class II, upper right ; class III, lower left , and class IV, lower right . Ligands are indicated by green triangles. Orientations of the half-sites are indicated by arrows .

The sequences flanking the palindromic (a palindrome is a nucleic acid sequence that is the same whether read 5′–3′ on one strand or 5′–3′ on the complementary strand of a double helix) responsive element (e.g., for the GR or ER) can play a role in the tightness of binding between the responsive element and the receptor.

Coactivators and Corepressors

Coactivator proteins interact directly with certain steroid hormone receptors and stimulate transcription. There are at least 15 coactivators, so far. A summary of several of the coactivator proteins and the receptors to which they bind is shown in Table 16.2 .

Table 16.2
Coactivator Proteins That Interact With Steroid Hormone Receptors.
Names Interacts With SN/NR Effect of SR Ligand on Direct Interaction Effect of Coexpression on Transcription Other Information
ACTR/SRC-3/ ERα Requires agonist ligand Stimulates E 2 -dependent transcription AIB1 expression elevated in human breast and ovarian cancers
RAC3/p/CIP/AIB1 RXRα
TR
ARA 70 (ELElα) ER Androgens and antiandrogens promote AR-ARA 70 interaction—also genistein and RU486 Stimulates AR transcription with DHT or E 2 No intrinsic HAT activity
Truncated ERα Interacts with p/CAF that has HAT activity
Variant ELE1 β GR Interacts with TFIIB
PPAR Highest ELElα and ERE1β expression in testis
CBP/p300/p270 AR, ERα, GR, PPARγ, RAR, RXR, TR, HNF-4 Requires agonist ligand, except for AR Stimulates transcription Intrinsic HAT activity CBP/p300 is also a cofactor for AP-1, c-myb, STAT1, E1A, p53, and Myo-D
RIP140 ERα, TR, RXR, PPARα, PPARγ Requires agonist ligand; antagonists tamoxifen and ICI 164,384 block interaction with ERα Stimulates ERα-induced transcriptionInhibits PPAR and RXR activities Identical to ERAP140
SRC-l/NoA-l AR, ERα, ERβl, PR, GR, TR, RARβ, RXRα, PPARγ, HNR4 Requires agonist ligand; antagonist inhibits interaction Stimulates PR, GR, and ERα-induced transcription Identical to ERAP160 and p160; intrinsic HAT activity, etc.; interacts with p300/CBP, TBP, and TFIIB
SWI/SNF ER, GR RAR, HNF-4 Stimulates transcription Chromatin remodeling complex in yeast with human homologs
TIF1α ERα, ERβ, PR, RXR, VDR Requires agonist ligand Stimulates transcription—requires agonist ligand for ERα, but for ERβ4-OHT acts as an agonist Interacts with heterochromatin proteins, including hSNF2b of the SWI/SNF complex and TIF1β
TIF2/GRIP1/NCoA-2 ERα, GR, AR, PR, RAR, RXR, TR, VDR HNF-4 Requires agonist ligand Stimulates ERα, AR, PR, TR, RAR, and RXR but not GR, or VDR 40% sequence homology to SRC-1
AIB1 , “Amplified In Breast” is NCOA3, a steroid receptor coactivator; AP-1 , heterodimeric protein transcription factor; AR , Androgen receptor; AR-ARA70 , a coactivator, especially of the AR; CBP/p300 , CREB (cAMP response element-binding protein) binding protein; c-myb , transcriptional activator and human protooncogene; E1A , transactivating protein; ELE1α , AR-specific coactivator; ERAP140 , tissue-specific nuclear coactivator; ERB4 , receptor protein tyrosine kinase; HAT , histone acetyltransferase; HNF-4 , hepatocyte nuclear factor 4 nuclear transcription factor binds DNA as homodimer; hSNF2b , mitotic growth and transcription activator; ICI164 , antiestrogen; Myo-D , myogenic-regulating factor involved in muscle differentiation; P/CAF , a histone acetylase and a nuclear receptor coactivator; p53 , tumor suppressor DNA-binding protein; RU486 , a synthetic antagonist of GR and PR; SRC-1 , transcriptional activator of nuclear receptors; STAT1 , transcriptional factor and signal transducer; SWI/SNF , “SWItch/SucroseNonFermentable” nucleosome-remodeling complex; TBP , TATA-binding protein; TFIIB , transcription factor, reacts with members of the steroid receptor superfamily; VDR , vitamin D receptor.

Coactivators bind to nuclear steroid receptors after the ligand binds to the receptor and a corepressor protein is dissociated from the receptor complex as shown in Fig. 16.18 .

Figure 16.18, Coactivator and corepressor complexes and histone acetylation . In the absence of ligand the nuclear hormone receptor heterodimer (in this case) is bound directly with the corepressor complex (shown on the upper left ). The corepressors SMRT/NCoR , associated with corepressor complexes , recruit HDACs either directly or through their interaction with Sin3 (a large protein that provides structural support for Sin3/HDAC complex). Many other proteins are involved in this complex. Deacetylation of histone tails leads to chromatin compaction and transcriptional repression . Ligand binding causes the release of the corepressor complex and allows the AF-2-dependent recruitment of a coactivator complex that contains p160 coactivators (e.g., p/CIP or SRC-1 ), CBP/p300 , and PCAF . All of these proteins possess HAT activity that allows chromatin decompaction and gene activation. Multiple protein–protein interactions exist among the different components: CBP/p300 contacts the receptor, the p160 coactivators, and PCAF through independent domains. The receptor itself binds CBP/p300, p160 coactivators, and PCAF. PCAF also can bind directly to CBP/p300, p160 coactivators, and to the receptor. HAT , Histone acetyltransferase; HDACs , histone deacetylases.

The major corepressors are NCoR and SMRT as shown in Table 16.3 where it describes with which specific receptors each corepressor interacts as well as additional information.

Table 16.3
Corepressor Proteins That Interact With Steroid/Nuclear Receptors.
Name Interacts With Effect of Coexpression on Transcription Other Information
NCoR TR Increased transcriptional activity of unliganded PR NCoR levels were reduced in many breast tumors that had acquired resistance to the antiproliferative effects of tamoxifen
RAR
RXR
PR
ERα
At high levels, NCoR increased RAR transcription
SMRT TR Increased transcriptional activity of unliganded PR HDAC1 is associated with SMRT
RXR
RAR
ERα
Overexpression strongly reduced basal and 4-OHT-stimulated gene expression with no effect on E 2 activity
ER , Estrogen receptor; PR , progesterone receptor; TR , thyroid hormone receptor.

These corepressors have a histone deacetylase (HDAC)-binding site and function by recruiting HDACs with other proteins to the receptor complexes at the promoter of gene target sequences. Unlike coactivators, corepressors themselves do not appear to have enzymatic activity but they are essential for the full activity of HDAC. When the nuclear receptor, like TR (thyroid receptor) or RAR (retinoic acid receptor) complexed with DNA, binds its ligand, the attached corepressor, NCoR, is dissociated allowing the attachment of coactivator complexes with histone acetyltransferase (HAT) activity to open DNA and enhance transcription.

Physiological Functions of Steroid Hormones From Specific Receptor Knockouts

Members of the steroid and nuclear receptor family are present in various concentrations in many or most tissues of the body. In the case of the GR , it has been shown to reside in the cytosols of all tissues, in various concentrations, except that it is absent from hepatobiliary cells and cells located in the region of the pars intermedia (in the human, there is no specific organ as in lower forms, only scattered cells with the described activities) of the anterior pituitary. Experimentally, it has been possible to “knock out” the genes for certain steroid receptors to create a homozygous knockout mouse . Following the knockout, the physiological effects of the loss in specific hormonal functions on the experimental mouse and its tissues are indicative of the actual roles of the steroids in the body. Knockout of the ERα did not result in death of the newborn but did result in infertility in both male and female animals. The uteri, ovaries, and mammaries of F-1 females were abnormal. Plasma levels of estradiol and LH (luteinizing hormone) were substantially higher than in wild-type animals although FSH (follicle-stimulating hormone) was relatively unaffected. There appeared to be heightened aggression toward other females. In males, lacking the ER, there was abnormal reproductive tract histology, infertile sperm, and smaller testicles than in the wild types. These males have reduced aggressive behavior over the normal wild types. Loss of the ER (and estrogen action), although not lethal, affects both female and male offspring in sexually related physiology and behavior.

There are several reproductive abnormalities in mice lacking the PR . In females the mammary gland does not develop normally and there is hyperplasia of the uterus . This knockout also was not lethal and sexual differentiation was normal, although females were infertile, whereas male fertility was unaffected. Circulating levels of LH were elevated about twofold (lack of negative feedback) but FSH levels were unchanged compared to normals. Thus the lack of progesterone function underscores the role of PRs in the regulation of hypothalamic and pituitary functions in the secretion of gonadotropins.

When the GR is knocked out, the offspring die shortly after birth by damage to the lung where the GR is essential for the development of surfactant . If neonatal animals were to survive in early development (which is not the case), the lack of ability to adapt to stress and environmental change would be lethal. In addition, there are effects on many other tissues, the functions of which rely on glucocorticoids, such as liver, brain, adrenals, thymus, bone marrow, and especially in the negative feedback regulation (via the GR) of the hypothalamic–pituitary axis. Thus cortisol and its receptor are essential for survival.

When the Mr is knocked out, offspring (mice) die within 2 weeks after birth. The animals die from loss of kidney reabsorption of water and sodium ions and they exhibit dehydration, hyperkalemia, loss of circulating sodium, and elevated levels of Ang II, aldosterone, and renin. There were elevations in expression of renin, angiotensinogen, and Ang II receptor (ST1) but the kidney level of angiotensin I-converting enzyme (ACE) was unchanged over normal controls.

AR deficiency is characteristic of the Tfm mouse (X-linked inherited disease) and these mice display the androgen insensitivity syndrome causing male mice to be infertile.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here